Lohrisch C - Search Results

1

Circulating tumour mutation detection in triple-negative breast cancer as an adjunct to tissue response assessment.

Zaikova E, Cheng BYC, Cerda V, Kong E, Lai D, Lum A, Bates C, den Brok W, Kono T, Bourque S, Chan A, Feng X, Fenton D, Gurjal A, Levasseur N, Lohrisch C, Roberts S, Shenkier T, Simmons C, Taylor S, Villa D, Miller R, Aguirre-Hernandez R, Aparicio S, Gelmon K. Zaikova E, et al. Among authors: lohrisch c. NPJ Breast Cancer. 2024 Jan 5;10(1):3. doi: 10.1038/s41523-023-00607-1. NPJ Breast Cancer. 2024. PMID: 38182588 Free PMC article.

2

Willingness of breast cancer patients to undergo biopsy and breast cancer clinicians' practices around seeking biopsy at the time of breast cancer relapse.

Lohrisch C, Francl M, Sun S, Villa D, Gelmon KA. Lohrisch C, et al. Breast Cancer Res Treat. 2018 Feb;168(1):221-228. doi: 10.1007/s10549-017-4586-9. Epub 2017 Nov 27. Breast Cancer Res Treat. 2018. PMID: 29181718

3

Impact of the 21-Gene Recurrence Score Assay on the Treatment of Estrogen Receptor-Positive, HER2-Negative, Breast Cancer Patients With 1-3 Positive Nodes: A Prospective Clinical Utility Study.

LeVasseur N, Sun J, Fenton D, Baxter S, Chan A, Roberts S, Feng X, Lohrisch C, Gelmon K, Shenkier T, Chia SK. LeVasseur N, et al. Among authors: lohrisch c. Clin Breast Cancer. 2022 Jan;22(1):e74-e79. doi: 10.1016/j.clbc.2021.09.004. Epub 2021 Sep 17. Clin Breast Cancer. 2022. PMID: 34690081

4

Survival with metastatic breast cancer based on initial presentation, de novo versus relapsed.

den Brok WD, Speers CH, Gondara L, Baxter E, Tyldesley SK, Lohrisch CA. den Brok WD, et al. Breast Cancer Res Treat. 2017 Feb;161(3):549-556. doi: 10.1007/s10549-016-4080-9. Epub 2016 Dec 20. Breast Cancer Res Treat. 2017. PMID: 28000014

5

Response to "Do metastasis-free interval less or more than 24 months for recurrent metastatic breast cancer and primary surgery for de novo metastatic breast cancer matter for survival?".

den Brok WD, Speers CH, Gondara L, Baxter E, Tyldesley SK, Lohrisch CA. den Brok WD, et al. Breast Cancer Res Treat. 2017 Apr;162(2):397-398. doi: 10.1007/s10549-017-4114-y. Breast Cancer Res Treat. 2017. PMID: 28110478 No abstract available.

6

Locoregional Recurrence and Survival Outcomes in Breast Cancer Treated With Modern Neoadjuvant Chemotherapy: A Contemporary Population-based Analysis.

Murchison S, Nichol A, Speers C, Gondara L, Levasseur N, Lohrisch C, Vallieres I, Truong P. Murchison S, et al. Among authors: lohrisch c. Clin Breast Cancer. 2022 Oct;22(7):e773-e787. doi: 10.1016/j.clbc.2022.07.003. Epub 2022 Jul 12. Clin Breast Cancer. 2022. PMID: 35915021

7

Impact of pathologic complete response on survival after neoadjuvant chemotherapy in early-stage breast cancer: a population-based analysis.

LeVasseur N, Sun J, Gondara L, Diocee R, Speers C, Lohrisch C, Chia S. LeVasseur N, et al. Among authors: lohrisch c. J Cancer Res Clin Oncol. 2020 Feb;146(2):529-536. doi: 10.1007/s00432-019-03083-y. Epub 2019 Nov 18. J Cancer Res Clin Oncol. 2020. PMID: 31741041

8

A prospective clinical utility and pharmacoeconomic study of the impact of the 21-gene Recurrence Score® assay in oestrogen receptor positive node negative breast cancer.

Davidson JA, Cromwell I, Ellard SL, Lohrisch C, Gelmon KA, Shenkier T, Villa D, Lim H, Sun S, Taylor S, Taylor M, Czerkawski B, Hayes M, Ionescu DN, Yoshizawa C, Chao C, Peacock S, Chia SK. Davidson JA, et al. Among authors: lohrisch c. Eur J Cancer. 2013 Jul;49(11):2469-75. doi: 10.1016/j.ejca.2013.03.009. Epub 2013 Apr 20. Eur J Cancer. 2013. PMID: 23611660

9

Impact of Recurrence Score on type and duration of chemotherapy in breast cancer.

Willemsma K, Yip W, LeVasseur N, Dobosz K, Illmann C, Baxter S, Lohrisch C, Simmons CE. Willemsma K, et al. Among authors: lohrisch c. Curr Oncol. 2020 Apr;27(2):e86-e92. doi: 10.3747/co.27.5635. Epub 2020 May 1. Curr Oncol. 2020. PMID: 32489257 Free PMC article.

10

Breast Cancer Molecular Subtype as a Predictor of Radiation Therapy Fractionation Sensitivity.

Lalani N, Voduc KD, Jimenez RB, Levasseur N, Gondara L, Speers C, Lohrisch C, Nichol A. Lalani N, et al. Among authors: lohrisch c. Int J Radiat Oncol Biol Phys. 2021 Jan 1;109(1):281-287. doi: 10.1016/j.ijrobp.2020.08.038. Epub 2020 Aug 24. Int J Radiat Oncol Biol Phys. 2021. PMID: 32853707 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

66 results

Search Page